<--- Back to Details
First PageDocument Content
Biotechnology / Veltuzumab / Milatuzumab / Labetuzumab / Systemic lupus erythematosus / Yttrium (90Y) clivatuzumab tetraxetan / Humanized antibody / Epratuzumab / Tolerx / Monoclonal antibodies / Anatomy / Medicine
Date: 2013-09-30 13:12:42
Biotechnology
Veltuzumab
Milatuzumab
Labetuzumab
Systemic lupus erythematosus
Yttrium (90Y) clivatuzumab tetraxetan
Humanized antibody
Epratuzumab
Tolerx
Monoclonal antibodies
Anatomy
Medicine

Microsoft Word - IMMUNOMEDICS AWARDED DOD GRANT FOR MILATUZUMAB IN LUPUS.doc

Add to Reading List

Source URL: www.immunomedics.com

Download Document from Source Website

File Size: 22,17 KB

Share Document on Facebook

Similar Documents

Biotechnology, BS

Biotechnology, BS "DBEFNJD.BQ  5IF"DBEFNJD.BQTFSWFTBTBTVHHFTUFEDPVSTFTFRVFODFPOMZ4UVEFOUTBSFOPUMJNJUFEUPUIJTQMBOJUJTNFBOUUPCFVTFEBT

DocID: 1xTqy - View Document

PDF Document

DocID: 1wroO - View Document

Building A Better Mousetrap:  Patenting Biotechnology In The European Community

Building A Better Mousetrap: Patenting Biotechnology In The European Community

DocID: 1vr7C - View Document

BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod

BIOTECH & PHARMA IN FRANCE KEY FACTS & FIGURES ¾¾ The French biotechnology sector ranks number 3 in Europe with more than 400 companies behind the UK and Germany ¾¾ First producer of medicines in Europe with 220 prod

DocID: 1vq6b - View Document

Biotechnology Consultation Agency Response Letter BNF

Biotechnology Consultation Agency Response Letter BNF

DocID: 1vpUZ - View Document